Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 3070741!ä!3070741 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Schweiz+Med+Wochenschr 1988 ; 118 (44): 1597-602 Nephropedia Template TP {{tp|p=3070741|t=1988. Magnesium in der Kardiologie Grundlagen und mogliche Indikationen |pdf=|usr=}}{{3070741}} gab.com Text Magnesium in der Kardiologie Grundlagen und mogliche Indikationen JO: Schweiz Med Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=3070741 #FOAvip The precise mechanism of magnesium effects on the heart is unknown. It may be based on calcium antagonism, prevention of vasospasm, enhancement of metabolic processes or inhibition of platelet aggregation. At present there are no established indications for parenteral magnesium administration. Probatory magnesium treatment can however be used in all tachyarrhythmias without major risk of adverse effects; in polymorphic ventricular tachycardia with QT prolongation (torsade de pointes) it can be recommended as a primary measure. Further investigations are needed to confirm the so far encouraging results of prophylactic intravenous magnesium administration in acute myocardial infarction. Twit Text FOAVip Magnesium in der Kardiologie Grundlagen und mogliche Indikationen ????Schweiz Med Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=3070741 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=3070741 #FOAvip English Wikipedia <ref>{{Cite pmid|3070741}}</ref> Magnesium in der Kardiologie Grundlagen und mogliche Indikationen #MMPMID3070741 Weiss M; Hess T Schweiz Med Wochenschr 1988[Nov]; 118 (44): 1597-602 PMID3070741show ga The precise mechanism of magnesium effects on the heart is unknown. It may be based on calcium antagonism, prevention of vasospasm, enhancement of metabolic processes or inhibition of platelet aggregation. At present there are no established indications for parenteral magnesium administration. Probatory magnesium treatment can however be used in all tachyarrhythmias without major risk of adverse effects; in polymorphic ventricular tachycardia with QT prolongation (torsade de pointes) it can be recommended as a primary measure. Further investigations are needed to confirm the so far encouraging results of prophylactic intravenous magnesium administration in acute myocardial infarction. |Heart Conduction System/drug effects[MESH] |Heart/*drug effects[MESH] |Hemodynamics/drug effects[MESH] |Humans[MESH] |Magnesium/pharmacokinetics/*pharmacology/therapeutic use[MESH] |Myocardial Infarction/drug therapy[MESH]Magnesium in der Kardiologie Grundlagen und mogliche Indikationen (epmc).pdf DeepDyve Pubget Overpricing